Theophylline Dosing Recommendations
The recommended dosing for theophylline must be individualized based on serum concentration monitoring, with a target therapeutic range of 5-15 mcg/mL at steady state, due to wide interpatient variability in theophylline clearance. 1
Initial Dosing Recommendations
Children
Children <45 kg:
- Starting dose: 12-14 mg/kg/day divided every 4-6 hours (maximum 300 mg/day)
- After 3 days, if tolerated: 16 mg/kg/day (maximum 400 mg/day)
- After 3 more days, if tolerated: 20 mg/kg/day (maximum 600 mg/day) 2
Age-specific dosing:
Adults
- Adults <60 years without risk factors:
Special Populations
- Patients with risk factors for impaired clearance, elderly (>60 years), or when monitoring is not feasible:
- Children 1-15 years: Maximum 16 mg/kg/day (not exceeding 400 mg/day)
- Adults and elderly: Maximum 400 mg/day 2
Monitoring and Dose Adjustment
Serum concentration monitoring:
Monitoring frequency:
- Acutely ill patients: Every 24 hours
- Rapidly growing children: Every 6 months
- All others: Yearly intervals 2
Dose adjustments:
- Make adjustments at intervals of no less than 3 days
- Base adjustments on serum theophylline concentration measurements
- Discontinue any dosage causing adverse effects and resume at lower, previously tolerated dose 2
Important Considerations and Cautions
Risk factors affecting clearance:
Adverse effects:
Drug interactions:
Special Clinical Situations
Acute bronchodilation:
Neonates with perinatal asphyxia:
- A single dose of theophylline may be given in neonates with severe perinatal asphyxia at high risk of acute kidney injury 1
Patients on maintenance theophylline presenting with acute asthma:
- Check serum levels before administering additional theophylline
- Most patients (68%) already have therapeutic levels and may not require additional IV theophylline 5
Common Pitfalls to Avoid
Failing to monitor serum concentrations - Essential due to 4-fold variation in clearance among similar patients 2
Increasing dose too rapidly - Wait at least 3 days between dose increases to allow steady state to be reached 2
Ignoring risk factors for reduced clearance - Adjust dosing in patients with concurrent URTI (reduce dose by ~40%) 4
Calculating dose based on actual rather than ideal body weight - Theophylline distributes poorly into body fat 2
Administering loading doses unnecessarily - For patients already on maintenance therapy presenting with acute symptoms, check levels first 5
By following these recommendations and carefully monitoring serum concentrations, theophylline can be used effectively while minimizing the risk of toxicity.